跳至主要内容
临床试验/ISRCTN11333136
ISRCTN11333136已完成未知

A randomised control trial to examine the efficacy of neurocognitive training as an intervention for helping breast cancer survivors improve and sustain their work ability by targeting impaired cognitive function

Birkbeck College, University of London0 个研究点目标入组 80 人开始时间: 2019年1月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 06/02/2019:
  • 1. 'Must be between 6 months to 60 months since the end of their active cancer treatment (i.e. no longer receiving chemotherapy and/or radiotherapy)
  • 2. Receiving hormone replacement therapies or target therapies (i.e. Herceptin injections)
  • 3. Clinical diagnosis of primary breast cancer
  • 4. Aged between 18 years old and 65 years old
  • 5. Attending paid work at the time of recruitment (note, there is no limit to the number of hours but the work must be considered regular)
  • 6. Experiencing a decline in their work ability as a direct result of cognitive difficulties
  • Previous inclusion criteria as of 05/02/2019:
  • 1. 'Must be between 12 months to 60 months since the end of their active cancer treatment (i.e. no longer receiving chemotherapy and/or radiotherapy)
  • 2. Receiving hormone replacement therapies or target therapies (i.e. Herceptin injections)
  • 3. Clinical diagnosis of primary breast cancer
  • 4. Aged between 18 years old and 65 years old
  • 5. Attending paid work at the time of recruitment (note, there is no limit to the number of hours but the work must be considered regular)
  • 6. Experiencing a decline in their work ability as a direct result of cognitive difficulties
  • Previous inclusion criteria:
  • Breast cancer survivors:
  • 1. Must be between 12 months to 36 months since the end of their active cancer treatment (i.e. no longer receiving chemotherapy and/or radiotherapy)
  • 2. Receiving hormone replacement therapies or target therapies (i.e. Herceptin injections)
  • 3. Clinical diagnosis of primary breast cancer
  • 4. Aged between 18 years old and 50 years old
  • 5. Attending paid work at the time of recruitment (note, there is no limit to the number of hours but the work must be considered regular)
  • 6. Experiencing a decline in their work ability as a direct result of cognitive difficulties

排除标准

  • Current exclusion criteria as of 20/05/2019:
  • Breast Cancer survivors:
  • 1. Receiving active cancer treatments including, chemotherapy and/or radiotherapy
  • 2. Under 6-months since the completion of active treatment for both chemotherapy and/or radiotherapy
  • 3. Clinical diagnosis of secondary or metastatic breast cancer
  • 4. Over the age of 65 years old at the time of recruitment
  • 5. Not attending paid work at the time of recruitment
  • 6. Not experiencing any changes or difficulties in their work ability associated with cognitive impairment(s)
  • 7. Unable to read or understand English
  • Previous exclusion criteria:
  • Breast cancer survivors:
  • 1. Receiving active cancer treatments including, chemotherapy and/or radiotherapy
  • 2. Under 12 months since the completion of active treatment for both chemotherapy and/or radiotherapy
  • 3. Clinical diagnosis of secondary or metastatic breast cancer
  • 4. Over the age of 50 years old at the time of recruitment
  • 5. Not attending paid work at the time of recruitment
  • 6. Not experiencing any changes or difficulties in their work ability associated with cognitive impairment(s)
  • 7. Unable to read or understand English

研究者

发起方
Birkbeck College, University of London

相似试验